9450sek
-2,1 %
Date:2025-05-23Time:18:00:00Latest report:Q1-2025List:Large CapTicker:ALVO SDB
Market Cap:30 694 msekEnterprise Value:43 151 msekNet Sales:370,9 musdEarnings:96,5 musdEmployees:0ISIN:SE0025011463

Ratios

10-year key figure history for Alvotech SDB turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for Alvotech SDB with index and moving average MA50 and MA200.

Stockprice:94,50
MA50:-
MA200:-
Price/MA200:-
RSI (14):-
Price/MA50:-

Description

Alvotech is a biotechnology company that focuses on the development and manufacture of biosimilar medicines. The company's pipeline consists of biosimilar candidates aimed at treating autoimmune diseases, eye diseases, osteoporosis and cancer. The company offers its products to patients all over the world. Alvotech was founded in 2013 and has its headquarters in Luxembourg.

Biotechnology